These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16244394)

  • 1. Correlation between metal ions and clinical findings in subjects affected by Alzheimer's disease.
    Bomboi G; Marchione F; Sepe-Monti M; De Carolis A; Bianchi V; Medda E; Pino A; Bocca B; Forte G; D'Ippolito C; Giubilei F
    Ann Ist Super Sanita; 2005; 41(2):205-12. PubMed ID: 16244394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease.
    Bocca B; Forte G; Petrucci F; Pino A; Marchione F; Bomboi G; Senofonte O; Giubilei F; Alimonti A
    Ann Ist Super Sanita; 2005; 41(2):197-203. PubMed ID: 16244393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis.
    Alimonti A; Ristori G; Giubilei F; Stazi MA; Pino A; Visconti A; Brescianini S; Sepe Monti M; Forte G; Stanzione P; Bocca B; Bomboi G; D'Ippolito C; Annibali V; Salvetti M; Sancesario G
    Neurotoxicology; 2007 May; 28(3):450-6. PubMed ID: 17267042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.
    Gerhardsson L; Lundh T; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2008; 25(6):508-15. PubMed ID: 18463412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier.
    Nischwitz V; Berthele A; Michalke B
    Anal Chim Acta; 2008 Oct; 627(2):258-69. PubMed ID: 18809082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.
    Grudzien A; Shaw P; Weintraub S; Bigio E; Mash DC; Mesulam MM
    Neurobiol Aging; 2007 Mar; 28(3):327-35. PubMed ID: 16574280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
    Basun H; Forssell LG; Wetterberg L; Winblad B
    J Neural Transm Park Dis Dement Sect; 1991; 3(4):231-58. PubMed ID: 1772577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of metal profiles in serum during the progression of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Metallomics; 2014 Feb; 6(2):292-300. PubMed ID: 24343096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.
    Boström F; Hansson O; Gerhardsson L; Lundh T; Minthon L; Stomrud E; Zetterberg H; Londos E
    Neurobiol Aging; 2009 Aug; 30(8):1265-71. PubMed ID: 18191875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up study.
    Visconti A; Cotichini R; Cannoni S; Bocca B; Forte G; Ghazaryan A; Santucci S; D'Ippolito C; Stazi MA; Salvetti M; Alimonti A; Ristori G
    Ann Ist Super Sanita; 2005; 41(2):217-22. PubMed ID: 16244396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metals and oxidative stress in patients with Parkinson's disease.
    Forte G; Alimonti A; Pino A; Stanzione P; Brescianini S; Brusa L; Sancesario G; Violante N; Bocca B
    Ann Ist Super Sanita; 2005; 41(2):189-95. PubMed ID: 16244392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles.
    Beach TG; Wilson JR; Sue LI; Newell A; Poston M; Cisneros R; Pandya Y; Esh C; Connor DJ; Sabbagh M; Walker DG; Roher AE
    Acta Neuropathol; 2007 Jan; 113(1):13-21. PubMed ID: 17021755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased plasma antioxidants in patients with Alzheimer's disease.
    Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
    Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological correlates of cognitive decline in Alzheimer's disease.
    Thind K; Sabbagh MN
    Panminerva Med; 2007 Dec; 49(4):191-5. PubMed ID: 18091671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
    Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
    Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis and Alzheimer's disease.
    Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
    Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
    Blain JF; Aumont N; Théroux L; Dea D; Poirier J
    Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.